OnTarget™ is a powerful, new platform for detection of rare tumor mutations in tissue or plasma.

 

  • Detect 100 or more mutations in a single assay, without sample splitting
  • Quantify mutations present at 0.01% allele frequency and above
  • Enrich mutations extracted from plasma or FFPE in about 1 hour

 

Systems are available now

Request a quote

 


 

Detect and quantify tumor mutations

More sensitivity.  More accuracy.  More variants.

OnTarget™ is a highly sensitive, multiplexed mutation detection assay that is ideally suited for accurately quantifying actionable tumor mutations in tissue or plasma. Download the product specification.

Rapid assay integration

OnTarget™ enrichment kits

OnTarget™ is provided with complete reagent kits for integration with next-generation sequencing detection.  The OnTarget™ enrichment step adds only ~1 hour and replaces traditional targeted amplicon approaches.

 


 

Customizable panels

Choose from standard or custom assays

OnTarget™ can analyze hundreds of unique targets in parallel without sample splitting or loss in assay sensitivity – critical for detection of mutations in samples with limited signal. View our panels of actionable mutations or contact us for assay customization.

Single molecule sensitivity

Minimal input mass required

The OnTarget™ assay is sensitive to single molecules of mutant alleles allowing for confident analysis of limited mass samples – view the system specification for input mass requirements and corresponding mutant allele sensitivity limits based on sampling statistics.